title: Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive.
abstract: Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed childhood psychiatric disorder. We have found that a transgenic mouse bearing a human mutant thyroid receptor (TRbeta1) expresses all of the defining symptoms of ADHD--inattention, hyperactivity, and impulsivity--as well as a 'paradoxical' response to methylphenidate (MPH). As with ADHD, the behavioral phenotypes expressed by the TRbeta transgenic mice are dynamic and sensitive to changes in environmental conditions, stress, and reinforcement. TRbeta transgenic mice are euthyroid except for a brief period during postnatal development, but the behavioral phenotypes, elevated dopamine turnover, and paradoxical response to MPH persist into adulthood. Thus, like the vast majority of children with ADHD, the TRbeta transgenic mice exhibit the symptoms of ADHD in the complete absence of thyroid abnormalities. This suggests that even transient perturbations in developmental thyroid homeostasis can have long-lasting behavioral and cognitive consequences, including producing the full spectrum of symptoms of ADHD.
authors.affiliation: Program in Neuroscience, Vanderbilt University, Nashville, TN 37232-0325, USA.
authors.forename: W B
authors.initials: WB
authors.lastname: Siesser
authors.forename: J
authors.initials: J
authors.lastname: Zhao
authors.forename: L R
authors.initials: LR
authors.lastname: Miller
authors.forename: S-Y
authors.initials: SY
authors.lastname: Cheng
authors.forename: M P
authors.initials: MP
authors.lastname: McDonald
mesh_terms: D000367:Age Factors; D000704:Analysis of Variance; D000818:Animals; D001288:Attention / Q000502:physiology*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000502:physiology; D005260:Female; D018776:Genes, erbA / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006801:Humans; D006948:Hyperkinesis / Q000235:genetics*; D007175:Impulsive Behavior / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D037042:Thyroid Hormone Receptors beta / Q000235:genetics* / Q000378:metabolism; D018382:Thyroid Hormone Resistance Syndrome / Q000150:complications / Q000235:genetics / Q000378:metabolism; D013963:Thyroid Hormones / Q000378:metabolism; D019076:Transgenes / Q000235:genetics
chemical_list: D000697:Central Nervous System Stimulants; D037042:Thyroid Hormone Receptors beta; D013963:Thyroid Hormones; D008774:Methylphenidate